GlassScriptPhysician profile
James Arthur Stinson
NPI 1770144404
$8,208.16
in general payments reported to CMS, 2019-2025
11 companies · $3,941 in 2025
The $3,941 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $128 · 2021: $221 · 2022: $545 · 2023: $2,501 · 2024: $760 · 2025: $3,941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,268 · Food and Beverage: $2,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,268.14 |
| Food and Beverage | $2,933.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,880.74 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Advance Xp |
| Coloplast Corp | $607.35 | 2023-2025 | Titan |
| Kerecis Limited | $190.16 | 2019-2022 | |
| Olympus America INC. | $127.85 | 2020 | |
| Myovant Sciences INC. | $124.80 | 2021 | |
| Merck Sharp & Dohme LLC | $95.93 | 2021 | |
| Endo USA, INC. | $71.79 | 2024 | Xiaflex |
| Antares Pharma, INC. | $50.00 | 2023 | Xyosted, Tlando |
| Axonics, INC. | $22.34 | 2024 | Bulkamid, Axonics |
| Astellas Pharma US INC | $19.02 | 2023 | Xtandi |
| Teleflex LLC | $18.18 | 2023 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Stinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.